1. Volume 151, Issue 1, Pages 69-75 (October 2018)
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial 
B.G. Wortman, T. Bosse, R.A. Nout, L.C.H.W. Lutgens, E.M. van der Steen-Banasik, H. Westerveld, H. van den Berg, A. Slot, K.A.J. De Winter, K.W. Verhoeven-Adema, V.T.H.B.M. Smit, C.L. Creutzberg 
Gynecologic Oncology 
Volume 151, Issue 1, Pages (October 2018)
DOI: /j.ygyno
Copyright © 2018 The Authors Terms and Conditions

2. Fig. 1 A – Study design of the PORTEC-4a trial.
B – Decision tree of the molecular-integrated risk profile.
Gynecologic Oncology  , 69-75DOI: ( /j.ygyno )
Copyright © 2018 The Authors Terms and Conditions

3. Fig. 1 A – Study design of the PORTEC-4a trial.
B – Decision tree of the molecular-integrated risk profile.
Gynecologic Oncology  , 69-75DOI: ( /j.ygyno )
Copyright © 2018 The Authors Terms and Conditions

4. Fig. 2 Cumulative accrual of the PORTEC-4a trial.
Gynecologic Oncology  , 69-75DOI: ( /j.ygyno )
Copyright © 2018 The Authors Terms and Conditions